Sunflower Pharmaceutical Group Co., Ltd. (SHE:002737)
China flag China · Delayed Price · Currency is CNY
11.81
-0.09 (-0.76%)
Nov 13, 2026, 3:04 PM CST

SHE:002737 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,104852.821,0402,2872,3991,320
Short-Term Investments
-----304.42
Trading Asset Securities
1,4831,7551,2581,3151,449668.69
Cash & Short-Term Investments
2,5882,6082,2983,6023,8472,293
Cash Growth
18.40%13.47%-36.19%-6.38%67.77%27.52%
Accounts Receivable
251.31182.31584.93110.13184.25268.98
Other Receivables
46.028.8214.9541.4242.5712.21
Receivables
297.33191.13599.88151.56226.82281.19
Inventory
652.04617.43867.31873.19632.08709.64
Prepaid Expenses
-11.5431.6844.33.748.75
Other Current Assets
101.8773.6188.23116.81151.03100.11
Total Current Assets
3,6393,5023,8864,7884,8613,393
Property, Plant & Equipment
1,1221,2081,3111,4351,4971,577
Long-Term Investments
56.6394.8897.12122.44141.38131.32
Goodwill
56.4456.4486.9891.7791.77107.6
Other Intangible Assets
327.6312.73332.64345.37366.52337.77
Long-Term Deferred Tax Assets
68.8964.1537.6258.9256.5155.78
Long-Term Deferred Charges
3.496.7510.038.866.811.87
Other Long-Term Assets
100.5583.964.8931.3910.8530.77
Total Assets
5,3745,3285,8266,8827,0325,635

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
415.83421.62319.05734.6714.48547.18
Accrued Expenses
45.88136.84205.55233.76301.01124.75
Short-Term Debt
177.84108.490.0214.43420200
Current Portion of Leases
-4.444.954.465.593.5
Current Income Taxes Payable
54.355.964.7387.5360.2143.54
Current Unearned Revenue
300.75272.57285.68297.32551.54167.04
Other Current Liabilities
217.73201.6207.55147.8122.54166.6
Total Current Liabilities
1,2161,1521,0281,5202,1751,253
Long-Term Debt
30----33.57
Long-Term Leases
2.8934.037.6210.57.01
Long-Term Unearned Revenue
170.41178.83199.37342.08397.26389.08
Long-Term Deferred Tax Liabilities
1.753.014.957.619.8917.82
Other Long-Term Liabilities
-1.3----
Total Liabilities
1,4211,3381,2361,8772,5931,700

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
584584584584584584
Additional Paid-In Capital
929.06929.06918.43915.66889.99896.7
Retained Earnings
2,2852,3182,8683,2522,7162,256
Treasury Stock
------44
Comprehensive Income & Other
6.066.99.1612.2814.3816.77
Total Common Equity
3,8043,8384,3794,7634,2053,709
Minority Interest
149.23152.37210.86241.25234225.72
Shareholders' Equity
3,9533,9914,5905,0054,4393,935
Total Liabilities & Equity
5,3745,3285,8266,8827,0325,635

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
214115.938.9926.52436.08244.08
Net Cash (Debt)
2,3742,4922,2893,5763,4112,049
Net Cash Growth
9.70%8.85%-35.97%4.82%66.47%37.72%
Net Cash Per Share
3.864.253.916.135.823.52
Filing Date Shares Outstanding
654.74584584584584587.54
Total Common Shares Outstanding
654.74584584584584587.54
Working Capital
2,4232,3502,8583,2682,6862,140
Book Value Per Share
5.816.577.508.167.206.31
Tangible Book Value
3,4203,4693,9604,3263,7463,264
Tangible Book Value Per Share
5.225.946.787.416.425.56
Buildings
-1,5651,5671,6121,6041,589
Machinery
-1,1451,1211,0751,014982.56
Construction In Progress
-32.3630.8435.730.2919.15